BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36780330)

  • 21. FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients.
    Wang Z; Zhang C; Sun L; Liang J; Liu X; Li G; Yao K; Zhang W; Jiang T
    Oncotarget; 2016 Dec; 7(51):84587-84593. PubMed ID: 27829236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffuse gliomas with FGFR3-TACC3 fusion have characteristic histopathological and molecular features.
    Bielle F; Di Stefano AL; Meyronet D; Picca A; Villa C; Bernier M; Schmitt Y; Giry M; Rousseau A; Figarella-Branger D; Maurage CA; Uro-Coste E; Lasorella A; Iavarone A; Sanson M; Mokhtari K
    Brain Pathol; 2018 Sep; 28(5):674-683. PubMed ID: 28976058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FGFR3 signaling and function in triple negative breast cancer.
    Chew NJ; Nguyen EV; Su SP; Novy K; Chan HC; Nguyen LK; Luu J; Simpson KJ; Lee RS; Daly RJ
    Cell Commun Signal; 2020 Jan; 18(1):13. PubMed ID: 31987043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-Small Cell Lung Carcinoma With Clear Cell Features and FGFR3::TACC3 Gene Rearrangement : Clinicopathologic and Next Generation Sequencing Study of 7 Cases.
    Suster D; Mackinnon AC; Ronen N; Mejbel HA; Harada S; Suster S
    Am J Surg Pathol; 2024 Mar; 48(3):284-291. PubMed ID: 38084010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the Src Pathway Enhances the Efficacy of Selective FGFR Inhibitors in Urothelial Cancers with FGFR3 Alterations.
    Lima NC; Atkinson E; Bunney TD; Katan M; Huang PH
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Varied histomorphology and clinical outcomes of FGFR3-TACC3 fusion gliomas.
    McDonald MF; Athukuri P; Anand A; Gopakumar S; Jalali A; Patel AJ; Rao G; Goodman JC; Lu HC; Mandel JJ
    Neurosurg Focus; 2022 Dec; 53(6):E16. PubMed ID: 36455273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A metabolic function of FGFR3-TACC3 gene fusions in cancer.
    Frattini V; Pagnotta SM; Tala ; Fan JJ; Russo MV; Lee SB; Garofano L; Zhang J; Shi P; Lewis G; Sanson H; Frederick V; Castano AM; Cerulo L; Rolland DCM; Mall R; Mokhtari K; Elenitoba-Johnson KSJ; Sanson M; Huang X; Ceccarelli M; Lasorella A; Iavarone A
    Nature; 2018 Jan; 553(7687):222-227. PubMed ID: 29323298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a FGFR3-TACC3 fusion in esophageal cancer.
    Mizukami T; Sakai K; Naruki S; Taniyama T; Horie Y; Izawa N; Tsuda T; Fujino T; Boku N; Yasuda H; Fukunaga T; Nakajima TE; Nishio K
    Ann Oncol; 2017 Feb; 28(2):437-438. PubMed ID: 27771611
    [No Abstract]   [Full Text] [Related]  

  • 29. Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma.
    Wu Y; Jin W; Wang Q; Zhou J; Wang Y; Tan Y; Cui X; Tong F; Yang E; Wang J; Kang C
    Mol Ther; 2021 Nov; 29(11):3305-3318. PubMed ID: 34274537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinico-pathological and epigenetic heterogeneity of diffuse gliomas with FGFR3::TACC3 fusion.
    Métais A; Tauziède-Espariat A; Garcia J; Appay R; Uro-Coste E; Meyronet D; Maurage CA; Vandenbos F; Rigau V; Chiforeanu DC; Pallud J; Senova S; Saffroy R; Colin C; Edjlali M; Varlet P; Figarella-Branger D;
    Acta Neuropathol Commun; 2023 Jan; 11(1):14. PubMed ID: 36647073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions.
    Tamura R; Yoshihara K; Saito T; Ishimura R; Martínez-Ledesma JE; Xin H; Ishiguro T; Mori Y; Yamawaki K; Suda K; Sato S; Itamochi H; Motoyama T; Aoki Y; Okuda S; Casingal CR; Nakaoka H; Inoue I; Verhaak RGW; Komatsu M; Enomoto T
    Oncogenesis; 2018 Jan; 7(1):4. PubMed ID: 29358619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffuse Gliomas with FGFR3-TACC3 Fusions: Oncogenic Mechanisms, Hallmarks, and Therapeutic Perspectives.
    Picca A; Sansone G; Santonocito OS; Mazzanti CM; Sanson M; Di Stefano AL
    Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas.
    Granberg KJ; Annala M; Lehtinen B; Kesseli J; Haapasalo J; Ruusuvuori P; Yli-Harja O; Visakorpi T; Haapasalo H; Nykter M; Zhang W
    Neuro Oncol; 2017 Sep; 19(9):1206-1216. PubMed ID: 28379477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FGFR3-TACC3 Activates Mitochondrial Respiration via PIN4 Phosphorylation.
    Cancer Discov; 2018 Feb; 8(2):139. PubMed ID: 29330265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of Oncogenic Signal Activation by the Novel Fusion Kinase FGFR3-BAIAP2L1.
    Nakanishi Y; Akiyama N; Tsukaguchi T; Fujii T; Satoh Y; Ishii N; Aoki M
    Mol Cancer Ther; 2015 Mar; 14(3):704-12. PubMed ID: 25589496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RT-PCR assay to detect
    Priesterbach-Ackley LP; van Kuik J; Tops BBJ; Lasorella A; Iavarone A; van Hecke W; Robe PA; Wesseling P; de Leng WWJ
    Neurooncol Pract; 2024 Apr; 11(2):142-149. PubMed ID: 38496910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TACC3: a multi-functional protein promoting cancer cell survival and aggressiveness.
    Saatci O; Sahin O
    Cell Cycle; 2023; 22(23-24):2637-2655. PubMed ID: 38197196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enrichment of FGFR3-TACC3 Fusions in Patients With Bladder Cancer Who Are Young, Asian, or Have Never Smoked.
    Nassar AH; Lundgren K; Pomerantz M; Van Allen E; Harshman L; Choudhury AD; Preston MA; Steele GS; Mouw KW; Wei XX; McGregor BA; Choueiri TK; Bellmunt J; Kwiatkowski DJ; Sonpavde GP
    JCO Precis Oncol; 2018; 2():. PubMed ID: 33604498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coexisting FGFR3 p.K650T mutation in two FGFR3-TACC3 fusion glioma cases.
    Ballester LY; Moghadamtousi SZ; Leeds NE; Huse JT; Fuller GN
    Acta Neuropathol Commun; 2019 Apr; 7(1):63. PubMed ID: 31036092
    [No Abstract]   [Full Text] [Related]  

  • 40. DNA methylation analysis of glioblastomas harboring FGFR3-TACC3 fusions identifies a methylation subclass with better patient survival.
    Wu Z; Lopes Abath Neto O; Bale TA; Benhamida J; Mata D; Turakulov R; Abdullaev Z; Marker D; Ketchum C; Chung HJ; Giannini C; Quezado M; Pratt D; Aldape K
    Acta Neuropathol; 2022 Jul; 144(1):155-157. PubMed ID: 35567606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.